
The Delhi High Court on May 29 recorded an undertaking from Dr. Reddy’s Laboratories that it will not sell the Ozempic like drug in India, amid an ongoing patent infringement suit filed by Novo Nordisk A/S over the patent of blockbuster diabetes medication.